Number of items: 2.
2021
Croci, G. A.,
Au-Yeung, R. K. H.,
Reinke, S.,
Staiger, A. M.,
Koch, K.,
Oschlies, I.,
Richter, J.,
Poeschel, V.,
Held, G.,
Loeffler, M.,
Trümper, L.,
Rosenwald, A.,
Ott, G.,
Spang, Rainer,
Altmann, B.,
Ziepert, M. and
Klapper, W.
(2021)
SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status.
Annals of Oncology.
Fulltext not available.
2019
Staiger, A. M.,
Altenbuchinger, Michael,
Ziepert, M.,
Kohler, Christian,
Horn, H.,
Huttner, Michael ,
Huttl, K. S.,
Glehr, Gunther ,
Klapper, W.,
Szczepanowski, M.,
Richter, J.,
Stein, H.,
Feller, A. C.,
Moller, P.,
Hansmann, M. L.,
Poeschel, V.,
Held, G.,
Loeffler, M.,
Schmitz, N.,
Trumper, L.,
Pukrop, T.,
Rosenwald, A.,
Ott, G.,
Spang, Rainer ,
Emed Demonstrator Project, and
German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL),
(2019)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.
Leukemia 34, pp. 543-552.
Fulltext not available.
This list was generated on Thu Dec 12 00:27:35 2024 CET.